Insmed (INSM) Retained Earnings (2010 - 2026)
Insmed's (INSM) quarterly Retained Earnings came in at $4000.0 in Q1 2026, up 100.0% year-on-year from $2000.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$5.6 billion in Q4 2025.
Insmed (INSM) Retained Earnings (2010 - 2026) Analysis & Trends
Insmed's Retained Earnings history runs 17 years deep, the most recent figure standing at $4000.0 for Q1 2026.
- On a quarterly basis, Retained Earnings rose 100.0% year-over-year to $4000.0 in Q1 2026; TTM through Mar 2026 was $4000.0, a 100.0% increase from a year earlier, with the FY2025 full-year figure at -$5.6 billion, down 221.33% from the prior year.
- Retained Earnings grew to $4000.0 in Q1 2026 per INSM's latest filing, from -$5.6 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $6.2 billion in Q2 2025 and bottomed at -$5.6 billion in Q4 2025.
- The 5-year median for Retained Earnings is $2.4 billion (2022), against an average of $1.0 billion.
- Biggest YoY gain for Retained Earnings was 2698324.44% in 2022; the steepest drop was 2536555.0% in 2022.
- Year by year, Retained Earnings stood at $756000.0 in 2022, then soared by 411736.9% to $3.1 billion in 2023, then surged by 49.22% to $4.6 billion in 2024, then slumped by 221.33% to -$5.6 billion in 2025, then surged by 100.0% to $4000.0 in 2026.
- Per Business Quant, the three latest INSM Retained Earnings figures stand at $4000.0 (Q1 2026), -$5.6 billion (Q4 2025), and $2.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | -5.64 Bn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 6.18 Bn |
| Mar 31, 2025 | -4.62 Bn |
| Dec 31, 2024 | 4.65 Bn |
| Sep 30, 2024 | 4.61 Bn |
| Jun 30, 2024 | 3.94 Bn |
| Mar 31, 2024 | 3.14 Bn |
| Dec 31, 2023 | 3.11 Bn |
| Sep 30, 2023 | 2.97 Bn |
| Jun 30, 2023 | -3.10 Bn |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 756,000.00 |
| Sep 30, 2022 | -2.54 Bn |
| Jun 30, 2022 | 2.45 Bn |
| Mar 31, 2022 | 2.43 Bn |
| Dec 31, 2021 | 2.67 Bn |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | -2.04 Bn |